EMEA-000157-PIP01-07-M06 - paediatric investigation plan
belatacept
PIPHuman
Danish is available via eTranslation, the European Commission's machine translation service.
Translate to Danish | Important information about machine translation
Key facts
- Invented name
- Nulojix
- Active substance
- belatacept
- Therapeutic area
- Renal and urinary disorders
- Decision number
- P/0351/2024
- PIP number
- EMEA-000157-PIP01-07-M06
- Pharmaceutical form(s)
- Powder for concentrate for solution for infusion
- Condition(s) / indication(s)
- Prevention of rejection of transplanted kidney
- Route(s) of administration
- Intravenous use
- Contact for public enquiries
Bristol-Myers Squibb Pharma EEIG
Email: medical.information@bms.com
Tel. +44 1895523740- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date
- Compliance check done
- Nej